C. Winter

发表

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

W. Gerald, E. Rappaport, J. Maris, 2006, Cancer research.

Chromosome 1p and 11q deletions and outcome in neuroblastoma.

Hiroyuki Shimada, Cynthia Winter, John M Maris, 2005, The New England journal of medicine.

Germline PHOX2B mutation in hereditary neuroblastoma.

E. Rappaport, J. Maris, A. Carlisle, 2004, American journal of human genetics.

RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

Cynthia Winter, Sharon J Diskin, John M Maris, 2011, Proceedings of the National Academy of Sciences.

Copy number variation at 1q21.1 associated with neuroblastoma

Sharon J. Diskin, John M. Maris, Struan F. A. Grant, 2009, Nature.

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.

Nazneen Rahman, Joseph T. Glessner, Hakon Hakonarson, 2008, The New England journal of medicine.

Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma

S. Gregory, J. Maris, M. Kok, 2005, Oncogene.

Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial

D. Parsons, N. Ramirez, T. Alonzo, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma

J. Orange, J. Christensen, S. Asgharzadeh, 2011, Oncogene.

ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

E. Rappaport, J. Maris, Y. Mossé, 2003, Cancer Research.

Prevalence and functional consequence of PHOX2B mutations in neuroblastoma

J. Maris, Y. Mossé, N. Wasserman, 2008, Oncogene.

Chromosome arm 11q deletion predicts for neuroblastoma outcome: A Children’s Oncology Group study

J. Maris, K. Matthay, E. Attiyeh, 2005 .

Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status

J. Maris, E. Seiser, E. Attiyeh, 2008, Pediatric blood & cancer.

Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression

K. Cole, J. Maris, S. Diskin, 2007, Genes, chromosomes & cancer.

Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma

J. Orange, J. Christensen, S. Asgharzadeh, 2012, Oncogene.

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism

Andrew C. Wood, Nazneen Rahman, Sharon J. Diskin, 2015, Nature.

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

Nazneen Rahman, Sharon J. Diskin, John M. Maris, 2009, Nature Genetics.

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

Nazneen Rahman, Sharon J. Diskin, John M. Maris, 2011, Nature.

Abstract 3867: Understanding the neuroblastoma predisposition signal at chromosome 2q35: Identification of the β-BARD1 isoform as an oncogenic driver

K. Cole, E. Rappaport, M. Devoto, 2010 .

Detection of Single-Copy Chromosome 17q Gain in Human Neuroblastomas Using Real-Time Quantitative Polymerase Chain Reaction

Yael Mosse, John M Maris, J. Maris, 2003, Modern Pathology.

Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

H. Hakonarson, K. Cole, Eva Dizin, 2012, Cancer research.

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

H. Hakonarson, K. Cole, M. Devoto, 2012, Nature Genetics.

High‐resolution detection and mapping of genomic DNA alterations in neuroblastoma

Adam A. Margolin, Joel Greshock, Cynthia Winter, 2005, Genes, chromosomes & cancer.

Letters to the Editor No " Bias " toward the Null Hypothesis in Most Conventional Multipoint Nonparametric Linkage Analyses Comparison of Linkage Statistics Analyses Using All 200 Families and Using Only the 147 Informative Families

E. Rappaport, J. Maris, A. Carlisle, 2004 .

No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.

A. Look, J. Maris, P. White, 2002, Cancer Research.

Design and development of the molecular analysis for Therapy Choice (NCI-MATCH) Designated Laboratory Network.

A. Iafrate, J. Sklar, K. Flaherty, 2019, Journal of Clinical Oncology.

Erratum: Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma (Oncogene (2012) 31 (4859-4867) DOI: 10.1038/onc.2011.647)

J. Orange, J. Christensen, S. Asgharzadeh, 2012 .

Vitamin D and retinoblastoma. The presence of receptors and inhibition of growth in vitro.

D. Albert, S. Cohen, L. Key, 1988, Archives of ophthalmology.

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

W. Gerald, E. Rappaport, J. Maris, 2006, Cancer research.

Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

H. Hakonarson, K. Cole, Eva Dizin, 2012, Cancer research.